{{DISPLAYTITLE:β<sub>2</sub>-微球蛋白}}
{{Infobox gene}}
'''β2微球蛋白'''（{{lang-en|β<sub>2</sub>-microglobulin}}，缩写'''B2M'''）是[[MHC_Ⅰ类分子|MHC1類分子]]分子的组成部分之一，在所有有核的细胞中（即不包括[[红细胞|红细胞]]）都有表达<ref name="entrez_567">{{Cite web|title=B2M beta-2-microglobulin [Homo sapiens (human)]|url=http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=567|access-date=2022-03-16|work=NCBI|language=en}}</ref><ref name="pmid3312414">{{Cite journal|title=The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit|url=https://pubmed.ncbi.nlm.nih.gov/3312414|last=Güssow|first=D.|last2=Rein|first2=R.|date=1987-11-01|journal=Journal of Immunology (Baltimore, Md.: 1950)|issue=9|volume=139|pages=3132–3138|issn=0022-1767|pmid=3312414|last3=Ginjaar|first3=I.|last4=Hochstenbach|first4=F.|last5=Seemann|first5=G.|last6=Kottman|first6=A.|last7=Ploegh|first7=H. L.|access-date=2022-03-16|archive-date=2022-01-05|archive-url=https://web.archive.org/web/20220105155839/https://pubmed.ncbi.nlm.nih.gov/3312414/|dead-url=no}}</ref>。在人类基因组中，β2微球蛋白<ref name="pmid4586824">{{Cite journal|title=Complete amino acid sequence of β 2 -microglobulin|url=https://pubs.acs.org/doi/abs/10.1021/bi00748a001|last=Cunningham|first=Bruce A.|last2=Wang|first2=John L.|date=1973-11|journal=Biochemistry|issue=24|doi=10.1021/bi00748a001|volume=12|pages=4811–4822|language=en|issn=0006-2960|pmid=4586824|last3=Berggard|first3=Ingemar|last4=Peterson|first4=Per A.|access-date=2022-03-16|archive-date=2022-03-16|archive-url=https://web.archive.org/web/20220316192518/https://pubs.acs.org/doi/abs/10.1021/bi00748a001|dead-url=no}}</ref>由''B2M'' [[基因|基因]]所编码<ref name="pmid3312414"/><ref name="pmid6171820">{{Cite journal|title=Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin.|url=https://pnas.org/doi/full/10.1073/pnas.78.11.6613|last=Suggs|first=S V|last2=Wallace|first2=R B|date=1981-11|journal=Proceedings of the National Academy of Sciences|issue=11|doi=10.1073/pnas.78.11.6613|volume=78|pages=6613–6617|language=en|issn=0027-8424|pmc=PMC349099|pmid=6171820|last3=Hirose|first3=T|last4=Kawashima|first4=E H|last5=Itakura|first5=K}}</ref>。

==结构功能==
[[File:MHC_Class_1(Traditional_Chinese).svg|thumb]]中的位置]]
β<sub>2</sub>-微球蛋白位于细胞表面的α<sub>3</sub>链旁，但与α链不同的是，β<sub>2</sub>并没有[[跨膜蛋白|跨膜]]区域，且为非共价结合。在β<sub>2</sub>的“上方”（指远离细胞膜的一端）为α链的α<sub>1</sub>区和α<sub>2</sub>区，构成了MHC的肽结合区。

β<sub>2</sub>微球蛋白不止参与形成第一类MHC分子，还能组成与之类似的表面受体，如[[CD1|CD1]]和{{le|Alloantigen|Alloantigen|Qa}}等。

β2微球蛋白还有一个功能，就是能与{{le|HFE (基因)|HFE (gene)|HFE蛋白}}结合，来调控[[铁调素|铁调素]]在[[肝脏|肝脏]]中的表达。鐵調素會與[[肠上皮细胞|肠上皮细胞]]和[[巨噬细胞|巨噬细胞]]膜上的{{le|膜铁转运蛋白|ferroportin}}作用。可以降低食物中和紅血球回收的鐵質攝取，该功能的丧失会导致铁过量和[[血色沉著病|血色沉著病]]。

==临床意义==
在长期[[血液透析|血液透析]]的患者中，β2微球蛋白可以聚集成[[類澱粉蛋白|淀粉样纤维]]沉积在关节间隙，这种疾病被称为透析相关[[淀粉样变|淀粉样变性]]。

缺乏β2微球蛋白基因的小鼠模型已经被改造。这些小鼠证明β2微球蛋白对于[[MHC_Ⅰ类分子|MHC Ⅰ类分子]]的细胞表面表达和肽结合沟的稳定性是必需的。事实上，在没有β2微球蛋白的情况下，可以在表面检测到数量非常有限的MHC I类分子。在没有MHC I类分子的情况下，[[CD8受体|CD8]] [[T细胞|T细胞]]不能生长（CD8 T细胞是参与获得性免疫发展的T细胞的一个子集）。低水平的β2微球蛋白可显示[[人類免疫缺陷病毒|HIV]]的非进展性。

[[多發性骨髓瘤|多发性骨髓瘤]]和[[淋巴瘤|淋巴瘤]]的β-2微球蛋白水平可能升高，但在这些情况下，原发性淀粉样变性（淀粉样轻链）和继发性淀粉样变性（淀粉样相关蛋白）更常见。β-2微球蛋白的正常值为<2 mg/L<ref name="isbn0-07-141184-4">{{cite book|author=Pignone M, Nicoll D; McPhee SJ|title=Pocket guide to diagnostic tests|url=https://archive.org/details/isbn_9780071411844|edition=4th|publisher=McGraw-Hill|location=New York|year=2004|pages=[https://archive.org/details/isbn_9780071411844/page/191 191]|isbn=0-07-141184-4}}</ref>。 然而，对于多发性骨髓瘤，β2微球蛋白的水平也可能处于谱的另一端。多发性骨髓瘤的诊断检测包括获取β2微球蛋白水平，因为该水平是一个重要的预后指标,水平<4 mg/L的患者的中位生存期预计为43个月，而水平>4 mg/L的患者的中位生存期仅为12个月<ref name="isbn0-07-174889-X">{{cite book|editor=Loscalzo J, Longo DL, Fauci AS, Dennis LK, Hauser SL|title=Harrison's Principles of Internal Medicine|author=Munshi NC, Longo DL, Anderson KC|chapter=Chapter 111: Plasma Cell Disorders|pages=936–44|edition=18th|publisher=McGraw-Hill Professional|location=|year=2011|isbn=0-07-174889-X}}</ref>。β-2微球蛋白水平不能区分预后较好的不确定意义的{{Le|单克隆免疫球蛋白血症|Monoclonal gammopathy of undetermined significance}}（MGUS）和隐匿性（低度）骨髓瘤<ref>{{Cite journal|title=MGUS and Smoldering Multiple Myeloma: Update on Pathogenesis, Natural History, and Management|url=https://ashpublications.org/hematology/article/2005/1/340/19260/MGUS-and-Smoldering-Multiple-Myeloma-Update-on|last=Rajkumar|first=S. Vincent|date=2005-01-01|journal=Hematology|issue=1|doi=10.1182/asheducation-2005.1.340|volume=2005|pages=340–345|language=en|issn=1520-4391|access-date=2022-03-16|archive-date=2022-03-16|archive-url=https://web.archive.org/web/20220316193138/https://ashpublications.org/hematology/article/2005/1/340/19260/MGUS-and-Smoldering-Multiple-Myeloma-Update-on|dead-url=no}}</ref><ref>{{Cite journal|title=Serum levels of beta 2 microglobulin and interleukin-6 to differentiate monoclonal gammopathy of undetermined significance [letter; comment]|url=https://ashpublications.org/blood/article/80/9/2433/48132/Serum-levels-of-beta-2-microglobulin-and|last=Bataille|first=R|last2=Klein|first2=B|date=1992-11-01|journal=Blood|issue=9|doi=10.1182/blood.V80.9.2433.bloodjournal8092433|volume=80|pages=2433–2434|language=en|issn=0006-4971}}</ref>。

==参考文献==
{{Reflist}}

==延伸阅读==
{{ReflistH|2}}
{{PBB Further reading
| citations = 
*{{Cite journal|title=β2-Microglobulin Signaling Blockade Inhibited Androgen Receptor Axis and Caused Apoptosis in Human Prostate Cancer Cells|url=http://clincancerres.aacrjournals.org/lookup/doi/10.1158/1078-0432.CCR-08-0793|last=Huang|first=Wen-Chin|last2=Havel|first2=Jonathan J.|date=2008-09-01|journal=Clinical Cancer Research|issue=17|doi=10.1158/1078-0432.CCR-08-0793|volume=14|pages=5341–5347|language=en|issn=1078-0432|pmc=PMC3032570|pmid=18765525|last3=Zhau|first3=Haiyen E.|last4=Qian|first4=Wei Ping|last5=Lue|first5=Hui-Wen|last6=Chu|first6=Chia-Yi|last7=Nomura|first7=Takeo|last8=Chung|first8=Leland W.K.}}
*{{Cite journal|title=β2-Microglobulin Is a Signaling and Growth-Promoting Factor for Human Prostate Cancer Bone Metastasis|url=http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-5472.CAN-06-1996|last=Huang|first=Wen-Chin|last2=Wu|first2=Daqing|date=2006-09-15|journal=Cancer Research|issue=18|doi=10.1158/0008-5472.CAN-06-1996|volume=66|pages=9108–9116|language=en|issn=0008-5472|pmid=16982753|last3=Xie|first3=Zhihui|last4=Zhau|first4=Haiyen E.|last5=Nomura|first5=Takeo|last6=Zayzafoon|first6=Majd|last7=Pohl|first7=Jan|last8=Hsieh|first8=Chia-Ling|last9=Weitzmann|first9=M. Neale}}
*{{Cite journal|title=Beta-2 microglobulin in ESRD: an in-depth review|url=https://linkinghub.elsevier.com/retrieve/pii/S1073444903000785|last=Winchester|first=James F|last2=Salsberg|first2=Jamie A|date=2003-10|journal=Advances in Renal Replacement Therapy|issue=4|doi=10.1053/j.arrt.2003.11.003|volume=10|pages=279–309|language=en|pmid=14681859|last3=Levin|first3=Nathan W|access-date=2022-03-16|archive-date=2022-03-03|archive-url=https://web.archive.org/web/20220303072313/https://linkinghub.elsevier.com/retrieve/pii/S1073444903000785|dead-url=no}}
*{{Cite journal|title=Proton NMR assignments and secondary structure of human .beta.2-microglobulin in solution|url=https://pubs.acs.org/doi/abs/10.1021/bi00152a030|last=Okon|first=Mark|last2=Bray|first2=Paul|date=1992-09-22|journal=Biochemistry|issue=37|doi=10.1021/bi00152a030|volume=31|pages=8906–8915|language=en|issn=0006-2960|last3=Vucelic|first3=Dusan|access-date=2022-03-16|archive-date=2022-03-16|archive-url=https://web.archive.org/web/20220316192541/https://pubs.acs.org/doi/abs/10.1021/bi00152a030|dead-url=no}}
*{{Cite journal|title=Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle|url=http://www.nature.com/articles/360364a0|last=Guo|first=Hwai-Chen|last2=Jardetzky|first2=Theodore S.|date=1992-11|journal=Nature|issue=6402|doi=10.1038/360364a0|volume=360|pages=364–366|language=en|issn=0028-0836|pmid=1448153|last3=Garrettt|first3=Thomas P. J.|last4=Lane|first4=William S.|last5=Strominger|first5=Jack L.|last6=Wiley|first6=Don C.|access-date=2022-03-16|archive-date=2022-03-14|archive-url=https://web.archive.org/web/20220314191019/https://www.nature.com/articles/360364a0|dead-url=no}}
*{{Cite journal|title=Beta 2-microglobulin gene is mutated in a human colon cancer cell line (HCT) deficient in the expression of HLA class I antigens on the cell surface|url=https://pubmed.ncbi.nlm.nih.gov/1737380|last=Gattoni-Celli|first=S.|last2=Kirsch|first2=K.|date=1992-03-01|journal=Cancer Research|issue=5|volume=52|pages=1201–1204|issn=0008-5472|pmid=1737380|last3=Timpane|first3=R.|last4=Isselbacher|first4=K. J.|access-date=2022-03-16|archive-date=2022-03-16|archive-url=https://web.archive.org/web/20220316192528/https://pubmed.ncbi.nlm.nih.gov/1737380/|dead-url=no}}
*{{Cite journal|title=Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution|url=https://linkinghub.elsevier.com/retrieve/pii/002228369190567P|last=Saper|first=M.A.|last2=Bjorkman|first2=P.J.|date=1991-05|journal=Journal of Molecular Biology|issue=2|doi=10.1016/0022-2836(91)90567-P|volume=219|pages=277–319|language=en|pmid=2038058|last3=Wiley|first3=D.C.|access-date=2022-03-16|archive-date=2022-03-03|archive-url=https://web.archive.org/web/20220303204236/https://linkinghub.elsevier.com/retrieve/pii/002228369190567P|dead-url=no}}
*{{Cite journal|title=Tumor necrosis factor, interleukin-1 and beta 2-microglobulin levels in chronic hemodialysis patients|url=https://pubmed.ncbi.nlm.nih.gov/2289831|last=Caruana|first=R. J.|last2=Lobel|first2=S. A.|date=1990-12|journal=The International Journal of Artificial Organs|issue=12|volume=13|pages=794–798|issn=0391-3988|pmid=2289831|last3=Leffell|first3=M. S.|last4=Campbell|first4=H.|last5=Cheek|first5=P. L.|access-date=2022-03-16|archive-date=2022-03-16|archive-url=https://web.archive.org/web/20220316192534/https://pubmed.ncbi.nlm.nih.gov/2289831/|dead-url=no}}
*{{Cite journal|title=In vitro formation of amyloid fibrils from intact β2-microglobulin|url=https://linkinghub.elsevier.com/retrieve/pii/0006291X85901986|last=Connors|first=L.H.|last2=Shirahama|first2=T.|date=1985-09|journal=Biochemical and Biophysical Research Communications|issue=3|doi=10.1016/0006-291X(85)90198-6|volume=131|pages=1063–1068|language=en|pmid=2413854|last3=Skinner|first3=M.|last4=Fenves|first4=A.|last5=Cohen|first5=A.S.|access-date=2022-03-16|archive-date=2019-12-05|archive-url=https://web.archive.org/web/20191205033529/https://linkinghub.elsevier.com/retrieve/pii/0006291X85901986|dead-url=no}}
*{{Cite journal|title=Specific associations of fluorescent beta-2-microglobulin with cell surfaces. The affinity of different H-2 and HLA antigens for beta-2-microglobulin|url=https://pubmed.ncbi.nlm.nih.gov/2450918|last=Hochman|first=J. H.|last2=Shimizu|first2=Y.|date=1988-04-01|journal=Journal of Immunology (Baltimore, Md.: 1950)|issue=7|volume=140|pages=2322–2329|issn=0022-1767|pmid=2450918|last3=DeMars|first3=R.|last4=Edidin|first4=M.|access-date=2022-03-16|archive-date=2022-03-16|archive-url=https://web.archive.org/web/20220316192523/https://pubmed.ncbi.nlm.nih.gov/2450918/|dead-url=no}}
*{{Cite journal|title=Collagen-Binding Affinity of Beta-2-Microglobulin, a Preprotein of Hemodialysis-Associated Amyloidosis|url=https://www.karger.com/Article/FullText/185699|last=Homma|first=Noriyuki|last2=Gejyo|first2=Fumitake|date=1989|journal=Nephron|issue=1|doi=10.1159/000185699|volume=53|pages=37–40|language=en|issn=1660-8151|pmid=2674742|last3=Isemura|first3=Mamoru|last4=Arakawa|first4=Masaaki}}
*{{Cite journal|title=In Vitro Production of Beta 2 Microglobulin by Human Myeloma Cells|url=http://www.tandfonline.com/doi/full/10.3109/07357908809080649|last=Bataille|first=Régis|last2=Grenier|first2=Jean|date=1988-01|journal=Cancer Investigation|issue=3|doi=10.3109/07357908809080649|volume=6|pages=271–277|language=en|issn=0735-7907|pmid= 3048575|last3=Commes|first3=Thérèse}}
*{{Cite journal|title=Correlation of beta-2-microglobulin concentration changes to changes of distribution volume|url=https://pubmed.ncbi.nlm.nih.gov/3060434|last=Hönig|first=R.|last2=Marsen|first2=T.|date=1988-11|journal=The International Journal of Artificial Organs|issue=6|volume=11|pages=459–464|issn=0391-3988|pmid=3060434|last3=Schad|first3=S.|last4=Barth|first4=C.|last5=Pollok|first5=M.|last6=Baldamus|first6=C. A.|access-date=2022-03-16|archive-date=2022-03-16|archive-url=https://web.archive.org/web/20220316192534/https://pubmed.ncbi.nlm.nih.gov/3060434/|dead-url=no}}
*{{Cite journal|title=Structure of the human class I histocompatibility antigen, HLA-A2|url=http://www.nature.com/articles/329506a0|last=Bjorkman|first=P. J.|last2=Saper|first2=M. A.|date=1987-10|journal=Nature|issue=6139|doi=10.1038/329506a0|volume=329|pages=506–512|language=en|issn=0028-0836|pmid=3309677|last3=Samraoui|first3=B.|last4=Bennett|first4=W. S.|last5=Strominger|first5=J. L.|last6=Wiley|first6=D. C.|access-date=2022-03-16|archive-date=2022-03-16|archive-url=https://web.archive.org/web/20220316192534/https://www.nature.com/articles/329506a0|dead-url=no}}
*{{Cite journal|title=The human beta 2-microglobulin gene. Primary structure and definition of the transcriptional unit|url=https://pubmed.ncbi.nlm.nih.gov/3312414|last=Güssow|first=D.|last2=Rein|first2=R.|date=1987-11-01|journal=Journal of Immunology (Baltimore, Md.: 1950)|issue=9|volume=139|pages=3132–3138|issn=0022-1767|pmid=3312414|last3=Ginjaar|first3=I.|last4=Hochstenbach|first4=F.|last5=Seemann|first5=G.|last6=Kottman|first6=A.|last7=Ploegh|first7=H. L.|access-date=2022-03-16|archive-date=2022-01-05|archive-url=https://web.archive.org/web/20220105155839/https://pubmed.ncbi.nlm.nih.gov/3312414/|dead-url=no}}
*{{Cite journal|title=Complete amino acid sequence of β 2 -microglobulin|url=https://pubs.acs.org/doi/abs/10.1021/bi00748a001|last=Cunningham|first=Bruce A.|last2=Wang|first2=John L.|date=1973-11|journal=Biochemistry|issue=24|doi=10.1021/bi00748a001|volume=12|pages=4811–4822|language=en|issn=0006-2960|pmid=4586824|last3=Berggard|first3=Ingemar|last4=Peterson|first4=Per A.|access-date=2022-03-16|archive-date=2022-03-16|archive-url=https://web.archive.org/web/20220316192518/https://pubs.acs.org/doi/abs/10.1021/bi00748a001|dead-url=no}}
*{{Cite journal|title=Use of synthetic oligonucleotides as hybridization probes: isolation of cloned cDNA sequences for human beta 2-microglobulin.|url=https://pnas.org/doi/full/10.1073/pnas.78.11.6613|last=Suggs|first=S V|last2=Wallace|first2=R B|date=1981-11|journal=Proceedings of the National Academy of Sciences|issue=11|doi=10.1073/pnas.78.11.6613|volume=78|pages=6613–6617|language=en|issn=0027-8424|pmc=PMC349099|pmid=6171820|last3=Hirose|first3=T|last4=Kawashima|first4=E H|last5=Itakura|first5=K}}
*{{Cite journal|title=Amino acid sequence of a modified β2-microglobulin in renal failure patient urine and long-term dialysis patient blood|url=https://linkinghub.elsevier.com/retrieve/pii/000989819506039G|last=Momoi|first=Tomoko|last2=Suzuki|first2=Masami|date=1995-05|journal=Clinica Chimica Acta|issue=2|doi=10.1016/0009-8981(95)06039-G|volume=236|pages=135–144|language=en|pmid=7554280|last3=Titani|first3=Koiti|last4=Hisanaga|first4=Shuichi|last5=Ogawa|first5=Hiroshi|last6=Saito|first6=Akira|access-date=2022-03-16|archive-date=2019-12-03|archive-url=https://web.archive.org/web/20191203175343/https://linkinghub.elsevier.com/retrieve/pii/000989819506039G|dead-url=no}}
*{{Cite journal|title=The three-dimensional structure of a class I major histocompatibility complex molecule missing the alpha 3 domain of the heavy chain.|url=https://pnas.org/doi/full/10.1073/pnas.92.4.1218|last=Collins|first=E J|last2=Garboczi|first2=D N|date=1995-02-14|journal=Proceedings of the National Academy of Sciences|issue=4|doi=10.1073/pnas.92.4.1218|volume=92|pages=1218–1221|language=en|issn=0027-8424|pmc=PMC42670|pmid=7862664|last3=Karpusas|first3=M N|last4=Wiley|first4=D C}}
*{{Cite journal|title=The addition of 5′-coding information to a 3′-directed cDNA library improves analysis of gene expression|url=https://linkinghub.elsevier.com/retrieve/pii/0378111994902933|last=Ryo|first=Matoba|last2=Kousaku|first2=Okubo|date=1994-09|journal=Gene|issue=2|doi=10.1016/0378-1119(94)90293-3|volume=146|pages=199–207|language=en|pmid=8076819|last3=Naohiro|first3=Hori|last4=Atsushi|first4=Fukushima|last5=Kenichi|first5=Matsubara|access-date=2022-03-16|archive-date=2019-12-04|archive-url=https://web.archive.org/web/20191204232936/https://linkinghub.elsevier.com/retrieve/pii/0378111994902933|dead-url=no}}
*{{Cite journal|title=Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA.|url=http://www.jci.org/articles/view/116249|last=Wang|first=Z|last2=Cao|first2=Y|date=1993-02-01|journal=Journal of Clinical Investigation|issue=2|doi=10.1172/JCI116249|volume=91|pages=684–692|language=en|issn=0021-9738|pmc=PMC288010|pmid=8432869|last3=Albino|first3=A P|last4=Zeff|first4=R A|last5=Houghton|first5=A|last6=Ferrone|first6=S|access-date=2022-03-16|archive-date=2019-12-29|archive-url=https://web.archive.org/web/20191229100200/https://www.jci.org/articles/view/116249|dead-url=no}}
}}
{{ReflistF}}

==外部链接==
* {{MeshName|beta+2-Microglobulin}}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. 
{{PBB Controls
| update_page = yes 
| require_manual_inspection = no 
| update_protein_box = yes
| update_summary = no
| update_citations = yes
}}-->
{{PDB Gallery|geneid=567}}
{{球状蛋白质}}
{{Amyloidosis}}

[[Category:免疫系统|Category:免疫系统]]